New vaccine trial to prevent melanoma cancer
The world’s first personalised mRNA cancer vaccine for melanoma halves the risk of patients dying or the disease.
Melanoma affects more than 150,000 people a year globally, according to 2020 figures from World Cancer Research Fund International.
Kingston Mills is a Professor of Experimental Immunology and Biochemistry at Trinity College Dublin and joins Seán to discuss.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.